AC Immune SA (ACIU) Financials
All currency values in CHF millions unless otherwise noted
Scroll
| Income Statement | TTM | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | CHF 18 | CHF 4 | CHF 27 | CHF 15 | CHF 4 | CHF 0 |
| Operating Income | -CHF 44 | -CHF 69 | -CHF 52 | -CHF 54 | -CHF 71 | -CHF 79 |
| Non-Operating | ||||||
| Net Interest Expense | -CHF 0 | -CHF 0 | -CHF 0 | -CHF 0 | -CHF 0 | -CHF 1 |
| Income Tax Expense | CHF 0 | CHF 0 | CHF 0 | CHF 0 | CHF 0 | CHF 0 |
| Net Income | ||||||
| Net Income | -CHF 43 | -CHF 70 | -CHF 51 | -CHF 54 | -CHF 71 | -CHF 73 |
| Per Share Data | ||||||
| Revenue Per Share | CHF 0.18 | CHF 0.04 | CHF 0.27 | CHF 0.20 | CHF 0.05 | CHF 0.00 |
| EPS (Basic) | -CHF 0.43 | -CHF 0.70 | -CHF 0.51 | -CHF 0.64 | -CHF 0.85 | -CHF 0.97 |
| EPS (Diluted) | -CHF 0.43 | -CHF 0.70 | -CHF 0.51 | -CHF 0.64 | -CHF 0.85 | -CHF 0.97 |
| Shares Outstanding | 98.7M | 100.8M | 99.8M | 74.8M | 76.1M | 68.3M |
AC Immune SA (ACIU) financials: revenue, profit and margins
AC Immune SA (ACIU) generated about CHF 18 million in revenue and -CHF 43 million in net income (a -246.5% net margin) over the trailing twelve months, growing at roughly -3.2% a year. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is AC Immune SA's (ACIU) revenue?+
AC Immune SA generated about CHF 18 million in revenue over the trailing twelve months. Revenue has grown at roughly -3.2% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is AC Immune SA profitable?+
AC Immune SA reported about -CHF 43 million in net loss over the trailing twelve months, a net margin of roughly -246.5%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are AC Immune SA's profit margins?+
AC Immune SA runs an operating margin of about -249.6%, a net margin of about -246.5%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is AC Immune SA growing?+
AC Immune SA's revenue has compounded at roughly -3.2% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside ACIU's margins and free cash flow. This is analysis from company filings, not investment advice.
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.